FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to a pharmaceutical, dietary, nutritional orally soluble composition for peroral intake, which contains at least one S-adenosylmethyonine (SAMe) salt in a combination with physiologically acceptable excipients and optionally other active ingredients. The physiologically acceptable excipients include light magnesium oxide.
EFFECT: compositions of the claimed invention have high taste qualities, which provides easier peroral introduction The compositions by the invention are characterised by the higher systemic bioavailability of S-adenosylmethyonine.
15 cl, 2 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING S-ADENOSYLMETHIONINE, AND ETHERS OF GALLIC ACID | 2013 |
|
RU2586300C1 |
| S-ADENOSYLMETHIONINE COMPOSITIONS FOR PERORAL APPLICATION | 2006 |
|
RU2427376C2 |
| METHOD OF APPLICATION OF GUAVA EXTRACT AND COMPOSITION, WHICH INCLUDES GUAVA EXTRACT | 2007 |
|
RU2405564C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING 5HT1-RECEPTOR AGONIST | 2002 |
|
RU2285526C2 |
| SPARKLING COMPOSITIONS | 2009 |
|
RU2460510C2 |
| METHOD FOR PREPARING S-ADENOSYLMETHIONINE CONTAINING TABLET | 2002 |
|
RU2313348C2 |
| IRON BIS-GLYCINATE CHELATE USED IN ORAL THERAPY OF ANAEMIA IN PATIENTS WITH CELIACIA | 2010 |
|
RU2541092C2 |
| COMPOSITION FOR THE TREATMENT OF VEISALGIA | 2017 |
|
RU2757379C2 |
| METHOD OF PRODUCING PHARMACEUTICAL COMPOSITION ADEMETIONINE AND DOSAGE FORM THEREOF | 2015 |
|
RU2587331C1 |
| DESMOPRESSIN MEDICINAL FORMULATION DISPERSED IN MOUTH CAVITY | 2003 |
|
RU2292903C2 |
